BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«KIR2DL4

Below is an extended KIR2DL4 research listing. Click here to return to the KIR2DL4 main in depth entry.

Recent Publications on KIR2DL4:

A critical look at HLA-G.
Human leukocyte antigen-G (HLA-G) is a nonclassical HLA class-I molecule...
Direct Link
3rd September, 2008
Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules. 14th August, 2008
Fox Chase Cancer Center, Division of Basic Science, Institute for Cancer
Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells.
Killer Ig-like receptor (KIR) expression is mostly restricted to NK cells...
Direct Link
1st July, 2008
Kathleen B. and Mason I. Lowance Center for Human Immunology and
The elucidation of KIR2DL4 gene polymorphism.
The killer cell immunoglobulin-like receptors (KIRs) on NK cells recognize...
Direct Link
25th April, 2008
Department of Pathology, University Medical Centre Utrecht, Utrecht, The
Human leukocyte antigen-G, a ligand for the natural killer receptor KIR2DL4, is expressed by eutopic endometrium only in the menstrual phase.
OBJECTIVE: To investigate menstrual cycle changes in expression by eutopic...
Direct Link
4th March, 2008
Departments of Obstetrics and Gynecology, Kochi Medical School, Kochi,
Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. 11th January, 2008
Department of Center Laboratory, Shandong Provincial Hospital, Shandong
[Analysis of natural killer cell immunoglobulin-like receptor gene family in HLA-identical sibling] 20th December, 2007
Blood Center of Zhejiang Province, Key Laboratory of Blood Safety
[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT] 15th December, 2007
Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow
Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
HLA-G5, -G6, and -G7 soluble isoforms of the immunosuppressive HLA-G...
Direct Link
31st October, 2007
Service de Recherches en Hemato-Immunologie, Commissariat a L'Energie
[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia] 31st October, 2007
Department of Histology and Embryology, Inner Monglia Medical College,
Allelic diversity in KIR2DL4 in a bone marrow transplant population: description of three novel alleles.
Genomic DNA sequencing was used to identify alleles of KIR2DL4 from 78...
Direct Link
25th August, 2007
Department of Oncology, CW Bill Young Marrow Donor Recruitment and
Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation. 22nd August, 2007
Department of Hematology, General Hospital of Air Force, Beijing 100036,
Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. 8th August, 2007
Department of Structural Biology, and Department of Microbiology and
Enrichment of individual KIR2DL4 sequences from genomic DNA using long-template PCR and allele-specific hybridization to magnetic bead-bound oligonucleotide probes.
DNA enrichment by allele-specific hybridization (DEASH) was used as a...
Direct Link
28th June, 2007
Anthony Nolan Research Institute, The Royal Free Hospital, London, UK.
KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.
In natural killer cells, killer immunoglobulin-like receptors (KIRs) loci...
Direct Link
28th June, 2007
Laboratorio de Inmunogenetica, Hospital de Clinicas, Facultad de Medicina,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional